- DBPR117: A Precision Medicine (mAb) Targeting RSPO3/Wnt-Mediated Tumorigenesis
- Abstract:Click here
- PowerPoint:Click here
- Neuroprotective Agent DBPR168 against Chemotherapy-Induced Peripheral Neuropathy
- Abstract:Click here
- PowerPoint:Click here
- DBPR376- New Luteinizing Hormone-Releasing Hormone Receptor (LHRHR)-Targeting Small Molecule Mertansine Conjugate for Cancer Treatment
- Abstract:Click here
- PowerPoint:Click here
- DBPR728: An Aurora kinase inhibitor for precision targeting of MYC-amplified solid tumors (A precision medicine strategy for cancers genetically addicted to MYC)
- Abstract:Click here
- DBPR807: A CXCR4-Targeted Antagonist
- Abstract:Click here
- PowerPoint:Click here
- DBPR22998: A Potent QPCTL (IsoQC) Inhibitor Targeting CD47-SIRPa Axis for Cancer Immunotherapy
- Abstract:Click here
- PowerPoint:Click here
- Method and composition for treatment of hair loss disorder
- Abstract:Click here
- PowerPoint:Click here
- Insect cell-based influenza virus-like particle (VLP) vaccines
- Abstract:Click here
- PowerPoint:Click here
- Method and composition for decreasing the psychotomimetic side effect and addictive disorder of ketamine
- Abstract:Click here
- PowerPoint:Click here